Bethea ED, Chen Q, Hur C, et al. Cost-effectiveness of Treating Acute versus Chronic Hepatitis C Infection Using Direct-Acting Antivirals. AASLD 2017, abstract 24.
Risankizumab veelbelovend voor behandeling van Crohn
apr 2024 | IBD
okt 2019
sep 2023